Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do

K Riesbeck1, A Bredberg, A Forsgren

  • 1Department of Medical Microbiology, University of Lund, Malmö General Hospital, Sweden.

Insights

Ciprofloxacin did not affect mitochondrial functions like DNA replication or protein synthesis at clinical doses. Other antibiotics, such as tetracyclines, did inhibit protein synthesis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Mitochondria are crucial for cellular energy production.
  • Antibiotics can have off-target effects on host cells.
  • Understanding antibiotic mitochondrial toxicity is important for patient safety.

Purpose of the Study:

  • To investigate the effects of ciprofloxacin on mitochondrial functions.
  • To compare ciprofloxacin's mitochondrial effects with other antibiotics.

Main Methods:

  • Assessing mitochondrial DNA replication.
  • Measuring oxidative phosphorylation.
  • Evaluating mitochondrial mass using transmembrane potential.
  • Analyzing supercoiled DNA forms.
  • Testing protein synthesis inhibition.

Main Results:

  • Ciprofloxacin did not inhibit mitochondrial DNA replication, oxidative phosphorylation, protein synthesis, or mitochondrial mass at clinical concentrations.
  • No changes in supercoiled DNA were observed with ciprofloxacin.
  • Tetracyclines and chloramphenicol inhibited protein synthesis at clinically achievable concentrations.
  • Rifampin, fusidic acid, and clindamycin did not inhibit protein synthesis.

Conclusions:

  • Ciprofloxacin appears safe regarding mitochondrial function at tested concentrations.
  • Certain antibiotics like tetracyclines and chloramphenicol exhibit protein synthesis inhibition, impacting mitochondria.
  • Further research may be needed to fully elucidate antibiotic-specific mitochondrial interactions.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...